KLRB1 and HIV infectious disease: In summary, the current study confirms and extends previous studies and suggests that an irreversible reduction of the peripheral CD161+ MAIT as well as an expansion of the CD161–TCR Vα7.2+ subset are early events in HIV infection [5]–[7], [24], [47].